Trial of a Chikungunya Vaccine, PXVX0317 CHIKV-VLP, in Healthy Adults

NCT03483961 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

445

Enrollment

INDUSTRY

Sponsor class

Conditions

Chikungunya Virus Infection

Interventions

BIOLOGICAL: CHIKV VLP/unadjuvanted
BIOLOGICAL: CHIKV VLP/adjuvanted
BIOLOGICAL: Placebo

Sponsor

Bavarian Nordic

Collaborators

[object Object]